Telos Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.88M | Buy |
62,415
+7,156
| +13% | +$560K | 0.5% | 76 |
|
|
2025
Q1 | $4.01M | Buy |
55,259
+3,665
| +7% | +$266K | 0.44% | 80 |
|
|
2024
Q4 | $3.82M | Sell |
51,594
-47,300
| -48% | -$3.5M | 0.41% | 80 |
|
|
2024
Q3 | $6.53M | Buy |
98,894
+1,519
| +2% | +$100K | 0.68% | 56 |
|
|
2024
Q2 | $8.99M | Buy |
97,375
+2,045
| +2% | +$189K | 1% | 33 |
|
|
2024
Q1 | $9.11M | Buy |
95,330
+3,925
| +4% | +$375K | 1.03% | 33 |
|
|
2023
Q4 | $6.97M | Buy |
91,405
+56,000
| +158% | +$4.27M | 0.85% | 38 |
|
|
2023
Q3 | $2.45M | Buy |
35,405
+4,555
| +15% | +$316K | 0.34% | 79 |
|
|
2023
Q2 | $2.91M | Buy |
+30,850
| New | +$2.91M | 0.39% | 74 |
|